Guidance

National Cancer Registration and Analysis Service: data users and partners

Guidance for all users of National Cancer Registration data on how to appropriately acknowledge use of the data on all outputs

From:
Public Health England
Published
15 December 2020

This publication was withdrawn on

On 1 October 2021, responsibility for the management of the National Disease Registration Service (NDRS) transferred from Public Health England (PHE) to NHS Digital. The information on this page is no longer in use. Please go to NHS Digital NDRS.

Documents

[Withdrawn] Acknowledging the use of the National Cancer Registration and Analysis Service

HTML

Details

This guidance has been published as part of the commitment to raise awareness of the cancer registry and the benefits brought about by the application and use of patient-level cancer data, in accordance with the National Data Guardian Review of Informed Choice for Cancer Registration.

Updates to this page

Published 15 December 2020

Sign up for emails or print this page

Related content